Andrew Lawrence, MD
Clinical Cardiac Electrophysiology · Hinsdale, ILNPI 1770502544
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (36.6%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Abbott accounts for 69.8% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $13,290 and has fallen 70.2% since, to $3,963 in 2025.
Across 381 payments — averaging $104.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$28K
- Boston Scientific$4K
- Biotronik Inc.$4K
- Medtronic$2K
- Impulse Dynamics (USA) Inc.$474
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$257
- plus $2K from 20 others
Across 34 payments — averaging $2053.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$62K
- Abbott$7K
What the payments were for
- Consulting fees$11,73929%
- Travel & lodging$13,52334%
- Food & beverage$14,58937%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 186 | $27,810 |
| Boston Scientific | 84 | $3,823 |
| Biotronik Inc. | 17 | $3,552 |
| Medtronic(3 entities) | 27 | $2,181 |
| Impulse Dynamics (USA) Inc. | 7 | $474 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 10 | $257 |
| Amgen | 11 | $216 |
| Boehringer Ingelheim | 4 | $209 |
| Cardiva Medical, Inc. | 6 | $195 |
| Cvrx, Inc. | 2 | $189 |
| Edwards Lifesciences | 2 | $164 |
| Atricure, Inc. | 2 | $163 |
| Johnson & Johnson | 5 | $111 |
| BD | 2 | $96 |
| Philips North America LLC | 1 | $72 |
| Shockwave Medical, Inc | 2 | $60 |
| Pfizer | 3 | $57 |
| Cardiovascular Systems Inc. | 1 | $55 |
| Terumo Medical Corporation | 1 | $35 |
| AstraZeneca | 2 | $27 |
| Stryker | 1 | $22 |
| Merck | 1 | $20 |
| Angiodynamics, Inc. | 1 | $19 |
| Cordis US CORP. | 1 | $16 |
| Cardinal Health 200 LLC | 1 | $15 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ensite Cardiac Mapping System$11,739
- AVEIR$5,443
- ENSITE$2,338
- GENERAL - THERAPIES$1,048
- EnSite Precision Cardiac Mapping System$937
- ENSITE PRECISION$895
- OPTIMIZER$744
- AMPLATZER AMULET$598
- Acticor 7 VR-T DX$529
- Micra$495
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$476
- Selectra$382
- Solia$382
- BioMonitor$382
- AMVIA EDGE$382
- Confirm Rx$303
- WATCHMAN Access System$229
- Watchman$226
- Unify Assura CRT Defibrillator$184
- Revo MRI$167
How this compares
$39,850 in reported general payments places this provider in the 65th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 490 | $476,591 |
| XareltoRivaroxaban | 84 | $103,206 |
| MultaqDronedarone Hcl | 15 | $25,088 |
| Flecainide Acetate | 137 | $4,590 |
| Propafenone Hcl ErPropafenone Hcl | 16 | $2,605 |
| Metoprolol Succinate | 136 | $2,548 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 96 | $2,271 |
| Mexiletine Hcl | 15 | $1,666 |
| Amiodarone Hcl | 84 | $1,339 |
| Diltiazem 24hr ErDiltiazem Hcl | 35 | $1,141 |
| Metoprolol Tartrate | 80 | $990 |
| ClopidogrelClopidogrel Bisulfate | 68 | $742 |
| Warfarin Sodium | 33 | $636 |
| Diltiazem 24hr Er (Xr)Diltiazem Hcl | 22 | $592 |
| SotalolSotalol Hcl | 43 | $568 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $57 | $476,591490 claims |
| Johnson & JohnsonXarelto | $111 | $103,20684 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in Hinsdale
- Francisco AguilarHinsdale$45K
- Mansour RazminiaPalos Heights$927K
- Mark MetzlEvanston$799K
- Roderick TungChicago$795K
- Bradley KnightChicago$661K
- Gaurav UpadhyayChicago$593K
- Henry HuangGeneva$501K
- Kousik KrishnanNaperville$311K
- Hany DemoChicago$297K
- Cash CaseyElmhurst$287K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.